Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
151.6 EUR | +1.78% | +6.23% | +15.24% |
Mar. 22 | REDCARE PHARMACY : Deutsche Bank reiterates its Buy rating | ZD |
Mar. 15 | REDCARE PHARMACY : Buy rating from Hauck & Aufhauser | ZD |
Sales 2024 * | 2.38B 2.57B | Sales 2025 * | 2.91B 3.13B | Capitalization | 3.06B 3.3B |
---|---|---|---|---|---|
Net income 2024 * | -6M -6.47M | Net income 2025 * | 49M 52.81M | EV / Sales 2024 * | 1.36 x |
Net Debt 2024 * | 172M 185M | Net Debt 2025 * | 156M 168M | EV / Sales 2025 * | 1.11 x |
P/E ratio 2024 * |
-459
x | P/E ratio 2025 * |
73.7
x | Employees | 1,900 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.9% |
Latest transcript on Redcare Pharmacy NV
1 day | +1.78% | ||
1 week | +6.23% | ||
Current month | +8.44% | ||
1 month | +6.83% | ||
3 months | +14.84% | ||
6 months | +57.22% | ||
Current year | +15.24% |
Managers | Title | Age | Since |
---|---|---|---|
Stephan Weber
FOU | Founder | - | 00-12-31 |
Marc Fischer
FOU | Founder | - | 00-12-31 |
Olaf Heinrich
CEO | Chief Executive Officer | 54 | 23-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Björn H. Söder
CHM | Chairman | 52 | 15-12-31 |
Frank Köhler
FOU | Founder | 60 | 00-12-31 |
Director/Board Member | 53 | 22-04-13 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.46% | 17 M€ | -.--% | - | |
0.02% | 735 M€ | -.--% | - | |
0.01% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 151.6 | +1.78% | 150,107 |
24-03-27 | 149 | +5.64% | 130,863 |
24-03-26 | 141 | -4.53% | 98,125 |
24-03-25 | 147.8 | +1.76% | 71,430 |
24-03-22 | 145.2 | +1.72% | 61,367 |
Delayed Quote Xetra, March 28, 2024 at 12:35 pm EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+15.24% | 3.31B | |
-16.93% | 18.7B | |
-29.16% | 11.29B | |
-2.30% | 6.68B | |
-1.85% | 5.5B | |
+8.03% | 5.13B | |
+34.14% | 3.9B | |
-9.09% | 3.76B | |
+3.99% | 3.51B | |
-15.22% | 3.33B |